Document Detail

The atherogenic potential of carbon monoxide.
MedLine Citation:
PMID:  8503943     Owner:  NLM     Status:  MEDLINE    
This paper reviews the available evidence concerning the atherogenic potential of carbon monoxide. The evidence comes from two different types of studies--epidemiology studies on populations of humans chronically exposed to carbon monoxide, and animal studies conducted under conditions of controlled exposure to carbon monoxide. Data from both epidemiology and animal studies suggest that carbon monoxide is not atherogenic. Therefore, the increased levels of atherosclerosis associated with smoking as reported in epidemiology studies of human smokers probably cannot be attributed to CO exposure.
C J Smith; T J Steichen
Related Documents :
383533 - Immunological and histopathological studies in a case of pyodermia vegetans hallopeau.
15178933 - Epidemiology of frontotemporal lobar degeneration.
7722563 - The accuracy of self-report of herpes zoster.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Atherosclerosis     Volume:  99     ISSN:  0021-9150     ISO Abbreviation:  Atherosclerosis     Publication Date:  1993 Mar 
Date Detail:
Created Date:  1993-06-30     Completed Date:  1993-06-30     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0242543     Medline TA:  Atherosclerosis     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  137-49     Citation Subset:  IM    
Bowman Gray Technical Center, R.J. Reynolds Tobacco Company, Winston-Salem, NC 27102.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Air Pollutants / adverse effects
Arteriosclerosis / chemically induced*
Carbon Monoxide / adverse effects*
Smoking / adverse effects
Reg. No./Substance:
0/Air Pollutants; 630-08-0/Carbon Monoxide
Erratum In:
Atherosclerosis 1993 Jun;101(1):127

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The activities of coenzyme Q10 and vitamin B6 for immune responses.
Next Document:  Relations of sodium-lithium countertransport kinetics to plasma and red cell membrane phospholipids ...